Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

Heart of the Rockies Regional Medical Center (HRRMC) has reported that it is feeling the effects of a nationwide shortage of intravenous (IV) fluids. Its main supplier of IV fluids, Baxter ...

Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to ...

[77] Bolus doses in the range of 625 mg to 2.5 g (12.5–50 mg/kg) have been fatal. Premixed injection solutions are available and may help reduce dosage errors. For patients on diuretic therapy ...

These categories of medications are generally taken orally (by mouth). However, some categories mentioned above have varying ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...

Federal regulators have approved a change to the expiration dates for multiple types of intravenous (IV) and sterile fluids made at a key manufacturing plant recovering from the impact of ...

Shortages of intravenous (IV) fluids, worsened by Hurricane Helene damage at Baxter's Marion ... "We are also increasing high concentration dextrose and sterile water for injection allocations and ...